A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 39,200 shares of IDXX stock, worth $16.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,200
Previous 48,800 19.67%
Holding current value
$16.5 Million
Previous $23.8 Million 16.74%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$455.08 - $517.19 $24.7 Million - $28.1 Million
-54,272 Reduced 70.14%
23,100 $11.7 Million
Q2 2024

Aug 14, 2024

BUY
$468.04 - $548.53 $16.4 Million - $19.3 Million
35,125 Added 83.14%
77,372 $37.7 Million
Q1 2024

May 15, 2024

SELL
$515.08 - $576.87 $51.3 Million - $57.5 Million
-99,625 Reduced 70.22%
42,247 $22.8 Million
Q4 2023

Feb 14, 2024

BUY
$391.37 - $557.56 $37.8 Million - $53.9 Million
96,605 Added 213.41%
141,872 $78.7 Million
Q3 2023

Nov 14, 2023

SELL
$432.42 - $556.67 $24.9 Million - $32.1 Million
-57,667 Reduced 56.02%
45,267 $19.8 Million
Q2 2023

Aug 14, 2023

SELL
$450.7 - $503.61 $274 Million - $307 Million
-608,965 Reduced 85.54%
102,934 $51.7 Million
Q1 2023

May 15, 2023

BUY
$406.01 - $514.59 $127 Million - $161 Million
313,801 Added 78.83%
711,899 $356 Million
Q4 2022

Feb 14, 2023

BUY
$324.64 - $441.27 $9.66 Million - $13.1 Million
29,767 Added 8.08%
398,098 $162 Million
Q3 2022

Nov 14, 2022

BUY
$325.8 - $407.78 $86 Million - $108 Million
264,023 Added 253.12%
368,331 $120 Million
Q2 2022

Aug 15, 2022

BUY
$327.37 - $553.44 $33.6 Million - $56.7 Million
102,533 Added 5776.51%
104,308 $36.6 Million
Q1 2022

May 16, 2022

SELL
$466.52 - $631.01 $152,552 - $206,340
-327 Reduced 15.56%
1,775 $971,000
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $27 Million - $30.6 Million
-45,973 Reduced 95.63%
2,102 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$621.9 - $705.76 $14.6 Million - $16.5 Million
23,432 Added 95.09%
48,075 $29.9 Million
Q1 2021

May 17, 2021

SELL
$465.18 - $551.79 $3.26 Million - $3.87 Million
-7,009 Reduced 22.14%
24,643 $12.1 Million
Q4 2020

Feb 16, 2021

SELL
$383.85 - $499.87 $57.9 Million - $75.4 Million
-150,908 Reduced 82.66%
31,652 $15.8 Million
Q3 2020

Nov 16, 2020

BUY
$334.54 - $406.31 $58.2 Million - $70.7 Million
173,899 Added 2007.84%
182,560 $71.8 Million
Q2 2020

Aug 14, 2020

BUY
$230.66 - $330.16 $1.14 Million - $1.63 Million
4,930 Added 132.14%
8,661 $2.86 Million
Q1 2020

May 15, 2020

SELL
$182.94 - $290.97 $367,160 - $583,976
-2,007 Reduced 34.98%
3,731 $904,000
Q2 2019

Aug 14, 2019

SELL
$215.53 - $275.33 $4.87 Million - $6.22 Million
-22,590 Reduced 79.74%
5,738 $1.58 Million
Q4 2018

Feb 14, 2019

BUY
$176.18 - $248.92 $1.99 Million - $2.81 Million
11,301 Added 66.37%
28,328 $5.27 Million
Q3 2018

Nov 13, 2018

SELL
$218.82 - $254.46 $1.54 Million - $1.79 Million
-7,022 Reduced 29.2%
17,027 $0
Q2 2018

Aug 10, 2018

SELL
$185.56 - $227.9 $10.3 Million - $12.6 Million
-55,446 Reduced 69.75%
24,049 $0
Q1 2018

May 11, 2018

BUY
$157.81 - $204.73 $5.39 Million - $7 Million
34,182 Added 75.44%
79,495 $15.2 Million
Q4 2017

Feb 09, 2018

BUY
$147.68 - $168.37 $5.99 Million - $6.83 Million
40,562 Added 853.76%
45,313 $7.09 Million
Q3 2017

Nov 09, 2017

BUY
$150.32 - $166.46 $714,170 - $790,851
4,751
4,751 $739,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $35.1B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.